NEWS: FDA APPROVAL OF A 2-MONTH LONG-ACTING ARIPIPRAZOLE INJ
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Dr. Saleem PK
NEWS: FDA APPROVAL OF A 2-MONTH LONG-ACTING ARIPIPRAZOLE INJECTION

Alkermes has formulated a once-in-two-months long-acting injection of aripiprazole. This formulation has been approved for marketing by the USA FDA and is expected to be available from mid-June, 2017.

Aripiprazole is now available in 4-week, 6-week, and 2-month long-acting injection formulations. These formualtions are 441 mg, 662 mg or 882 mg once monthly; 882 mg once in 6 weeks; and 1064 mg once in 2 months. Patients can be started on treatment with any dose and at any interval.

http://investor.alkermes.com/mobile.view?c=92211&v=203&d=1&id=2279079
Preview
Dr. J●●●l S●●h and 1 others like this
Like
Comment
Share